| Visualizaciones | |
|---|---|
| An in silico evaluation of lorlatinib as a potential therapy for novel amino acid substitutions in the tyrosine kinase domain of the ALK protein associated with cancer | 5 |
| octubre 2025 | noviembre 2025 | diciembre 2025 | enero 2026 | febrero 2026 | marzo 2026 | abril 2026 | |
|---|---|---|---|---|---|---|---|
| An in silico evaluation of lorlatinib as a potential therapy for novel amino acid substitutions in the tyrosine kinase domain of the ALK protein associated with cancer | 0 | 0 | 0 | 0 | 0 | 0 | 5 |
| Visualizaciones | |
|---|---|
| fphar-16-1605314.pdf | 1 |
| Visualizaciones | |
|---|---|
| Estados Unidos | 2 |
| Visualizaciones |
|---|